Clinical Trials Browser

Phase 2 × Completed × Peritoneal Neoplasms × Clear all

NCT04950166 2024-11-08

A Study to Evaluate ONM100, an Intraoperative Fluor Imaging Agent for the Detection of Peri Mets

Phase 2 Completed

51 enrolled 13 charts

Peritoneal Neoplasms

NCT02040142 2024-10-24

HIPEC for Peritoneal Carcinomatosis

Phase 2 Completed

51 enrolled 12 charts

GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Stomach Neoplasms, Colorectal Neoplasms

NCT02891447 2024-09-19

Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer

Phase 2 Completed

24 enrolled 10 charts

Peritoneal Neoplasms

NCT02399410 2024-01-30

Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis

Phase 2 Completed

GastrointestinalGynecologic

Peritoneal Neoplasms, Colorectal Neoplasms

NCT02567253 2023-11-27

OvIP1

Phase 2 Completed

Ovarian Neoplasms, Peritoneal Neoplasms

NCT01575730 2022-12-15

Cytoreduction Followed by Normothermic Versus Hyperthermic Intraperitoneal Intraoperative Chemoperfusion (HIPEC): a Study in Peritoneal Carcinomatosis

Phase 2 Completed

Peritoneal Neoplasms

NCT03287375 2022-10-07

PIPAC-OPC2

Phase 2 Completed

Peritoneal Neoplasms

NCT00391118 2020-10-19

Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill")

Phase 2 Completed

153 enrolled 20 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT03246321 2019-10-15

CRC-PIPAC

Phase 2 Completed

GastrointestinalGynecologic

Appendiceal Neoplasms, Cecal Neoplasms, Intraoperative Complications, Neoplasms, Peritoneal Neoplasms, Postoperative Complications, Colorectal Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT01833832 2019-07-30

Surgery and Heated Chemotherapy for Adrenocortical Carcinoma

Phase 2 Completed

11 enrolled 14 charts

EndocrineGynecologic

Hyperthermia, Peritoneal Neoplasms, Adrenocortical Carcinoma

NCT01523678 2019-07-10

Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers

Phase 2 Completed

Uterine Cervical Diseases, Uterine Cervical Neoplasms, Endocrine System Diseases, Fallopian Tube Diseases, Fallopian Tube Neoplasms, Genital Diseases, Female, Genital Neoplasms, Female, Neoplasms, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Peritoneal Diseases, Peritoneal Neoplasms, Urogenital Neoplasms, Uterine Diseases, Endometrial Neoplasms

NCT00326885 2018-10-17

Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites

Phase 2 Completed

32 enrolled 12 charts

Carcinoma, Ovarian Epithelial, Ascites, Carcinoma, Fallopian Tube Neoplasms, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Peritoneal Neoplasms

NCT01504256 2018-01-23

CatuNeo

Phase 2 Completed

Adenocarcinoma, Peritoneal Neoplasms

NCT02320448 2017-09-12

Treating Peritoneal Carcinomatosis With PIPAC

Phase 2 Completed

Peritoneal Neoplasms

NCT02739698 2017-08-01

Role of Intraperitoneal Intraoperative Chemotherapy With Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatosis From Ovarian Cancer. Hyperthermia Versus Normothermia

Phase 2 Completed

32 enrolled 5 charts

Ovarian Neoplasms, Peritoneal Neoplasms

NCT02638051 2017-05-19

OTMA-RII

Phase 2 Completed

260 enrolled 13 charts

Ascites, Peritoneal Neoplasms, Yin Deficiency, Yang Deficiency

NCT00112086 2016-08-31

OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT00004547 2015-11-18

Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy

Phase 2 Completed

188 enrolled 11 charts

GastrointestinalGynecologicOther solid neoplasmThoracic

Abdominal Neoplasms, Colonic Neoplasms, Mesothelioma, Peritoneal Neoplasms

NCT00318370 2015-09-09

Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy

Phase 2 Completed

58 enrolled 12 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT02032485 2014-10-15

OC-AP-ICG-IV

Phase 2 Completed

GastrointestinalGynecologic

Peritoneal Neoplasms, Colorectal Neoplasms

NCT00183794 2014-05-22

Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma

Phase 2 Completed

20 enrolled 8 charts

Ovarian Neoplasms, Peritoneal Neoplasms

NCT01379482 2014-05-06

Neo-adjuvant Chemo + Peritonectomy + Hyperthermic Intraperitoneal Chemo in Peritoneal Carcinomatosis From Gastric Cancer

Phase 2 Completed

GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT00698451 2013-09-06

A Study of Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers

Phase 2 Completed

54 enrolled 8 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT00035100 2012-04-16

EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer

Phase 2 Completed

Carcinoma, Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT00332696 2011-09-23

Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis

Phase 2 Completed

64 enrolled 17 charts

Carcinoma, Intestinal Obstruction, Peritoneal Neoplasms

NCT00517621 2011-02-25

Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms, Recurrence, Disease Progression

NCT00063401 2010-04-08

Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT00189345 2006-11-08

Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients

Phase 2 Completed

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT00074867 2006-11-07

Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms